Stockreport

Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid tumors [Financial Post (Toronto, Ontario, Canada)]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF Author of the article: You can save this article by registering for free here . Or sign-in if you have an account. STRO-003 targets ROR1, a clinically validated ant [Read more]